Paper Details

  1. Home
  2. Paper Details

Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.

Author: CangianoJ, DavidovM E, GlazerN, WollamG, ZagerP G

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Betaxolol was found to be as effective as and better tolerated than propranolol in the treatment of mild to moderate essential hypertension. It was also more effective in lowering blood pressure earlier in treatment.
Paper Details　
Original Abstract of the Article :
A double-blind, multicenter study compared the safety and efficacy of oral betaxolol 10 to 40 mg once daily (n = 68) with propranolol 40 to 160 mg twice daily (n = 73) in the treatment of mild to moderate essential hypertension. Both agents produced significant (P less than 0.01) and comparable redu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/ajh/1.3.206s

データ提供：米国国立医学図書館（NLM）

Beta-blockers: A Tale of Two Medications

Hypertension, or high blood pressure, is a common health concern. This study delves into the realm of beta-blockers, medications that help lower blood pressure. The researchers compared the effectiveness and safety of two beta-blockers, betaxolol and propranolol, in treating mild to moderate hypertension. They found that both drugs effectively reduced blood pressure and heart rate, but betaxolol was better tolerated, with fewer central nervous system side effects. Betaxolol also led to quicker blood pressure reduction, suggesting it might be a more effective option in the early stages of treatment.

A New Beta-blocker Takes the Stage

Beta-blockers have been a mainstay in hypertension management for decades, like the trusty camels that have been a staple of desert travel for centuries. This study reveals that betaxolol might offer a more comfortable ride, with fewer side effects and quicker results. However, it’s important to remember that each individual responds differently to medications, and the best treatment plan should be tailored to the specific needs of each patient.

Balancing the Scales

The findings suggest that betaxolol could be a preferred option for individuals with mild to moderate hypertension, offering a smoother journey with fewer side effects. However, it is essential to consult with a healthcare professional to determine the best course of action, as individual responses to medication can vary significantly.

Dr.Camel's Conclusion

This study shows that betaxolol, a new beta-blocker, is as effective as propranolol for treating mild to moderate hypertension but is better tolerated. This is a significant finding, suggesting that betaxolol could be a more suitable choice for some patients, just like choosing a camel that’s known for its gentle nature and surefootedness on a long desert trek. However, it's important to consult a healthcare professional to personalize treatment decisions.

Date :
  1. Date Completed 1988-10-19
  2. Date Revised 2019-05-10
Further Info :

Pubmed ID

2901266

DOI: Digital Object Identifier

10.1093/ajh/1.3.206s

Related Literature

Article Analysis
・Side Effects of betaxolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.